Actively hiring
Artificial Intelligence
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2023
Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Kelonia is revolutionizing gene delivery to expand the impact of genetic medicines; built on decades of research, development, and…

Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…

Vira Regen develops noninvasive, gene-targeted electrostimulation devices for bone regeneration. OsteoVolt is in preclinical development…

Blocks transforms your operations into a team of AI agents connected across your workflows and data.

ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our…

Building Modern Digital Products through the lens of AI-First Engineering Approach.
Overview
Nanograb is building the future of AI-powered targeted gene delivery.

Y Combinator 




